Brief: Aridis Announces The Closing Of Patient Enrollment In The Ar-301 Global Phase 3 Superiority Study

Aridis Pharmaceuticals

04/10/2022 13:37

Oct 4 (Reuters) - Aridis Pharmaceuticals Inc  ARDS.O :
    * ARIDIS ANNOUNCES THE CLOSING OF PATIENT ENROLLMENT IN THE
AR-301
GLOBAL PHASE 3 SUPERIORITY STUDY
    * ARIDIS PHARMACEUTICALS INC- ON TRACK TO COMPLETE DATA
COMPILATION AND ANALYSES, WITH TOP-LINE DATA EXPECTED TO BE
ANNOUNCED IN DECEMBER '22

Source text for Eikon:  ID:nPn6Cy6nxa 
Further company coverage:  ARDS.O 
 ((Reuters.Briefs@thomsonreuters.com;;))